国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
697例血栓通制剂不良反应的回顾性分析
Retrospective Analysis on 697 Cases of Adverse Drug Reaction of Xueshuantong Preparations
  
DOI:
中文关键词:  血栓通制剂  药品不良反应  安全用药  回顾性分析
英文关键词:Xueshuantong preparations  Adverse drug reaction  Safety of drug use  Retrospective analysis
基金项目:
作者单位
贺国芳 窦文孟 曾凡 华中科技大学同济医学院附属同济医院 ①药学部②胸部肿瘤科 (武汉 430030) 
摘要点击次数: 1059
全文下载次数: 1352
中文摘要:
      摘 要 目的:分析血栓通制剂不良反应(ADR)的发生特点,为临床合理用药提供参考。方法:回顾性分析2012年1月~2014年12月湖北省药品不良反应监测中心收集到的697例血栓通制剂所致ADR报告,统计分析ADR患者的年龄与性别分布、原发疾病和过敏史、用药方法,ADR发生的时间分布、因果关系及转归、累及系统 器官等。结果:血栓通制剂ADR报告中,女性略多于男性,且在各个年龄段均有分布;用药方法和剂量不当会使血栓通制剂ADR增多;多数不良反应发生在用药24 h内,且引起了一定数量的严重ADR;不良反应累及系统 器官多达十余个,其中以皮肤及其附件损害最多。结论:血栓通制剂使用不当可引起ADR,临床应严格遵循说明书用药并加强用药监测,同时生产厂家应对药品说明书做出补充和完善,从而减少该药ADR的发生。
英文摘要:
      ABSTRACT Objective:To analyze the occurrence characteristics on adverse drug reaction(ADR)of Xueshuantong preparations and provide reference for clinical rational drug use. Methods:697 cases of ADR reports of Xueshuantong preparations, from January 2012 to December 2014 of adverse drug reaction monitoring center in Hubei Province, were analyzed retrospectively, involving the statistics and analysis of the age and gender distribution, treatment methods, the primary diseases and allergies, time distribution of ADR, causality evaluation, and systems or organs involved and clinical manifestations of ADR. Results:In the ADR report of Xueshuantong preparations, women were slightly more than men, occurrence of ADR distributed various age groups; improper medication methods and dosage would make ADR of Xueshuantong preparations increase; most ADR occurred within 24 h, resulting in a certain number of serious ADR; systems or organs involved were up to 16, and the ADR were chiefly characterized by the damage of skin and appendages . Conclusion:Xueshuantong preparations might cause a large proportion of serious ADR, therefore, instructions should be strictly followed and more monitoring were needed while using. At the same time, the production manufacturers of Xueshuantong preparations ought to make supplement of drug instructions to reduce the occurrence of ADR.
查看全文  查看/发表评论  下载PDF阅读器
关闭